PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease†,‡

Speliotes, Elizabeth K., Butler, Johannah L., Palmer, Cameron D., Voight, Benjamin F., Hirschhorn, Joel N.·2010·Hepatology
DOI 10.1002/hep.23768

Cited by (362)

Items 301–362 of 362

  1. Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making
    Mayada Metwally, Mohammed Eslam, Jacob George · 2017 · Current Hepatology Reports
  2. Meta-Analysis Reveals a Specific Association of the Pnpla3 I148M Polymorphism with Alt Level in Adolescents
    Zhengtao Liu, Huaijun Ning, HE Xiao-yin, Shuping Que, Lin Zhou · 2015 · Personalized Medicine
  3. Diabetes and Liver Disease
    Douglas Meyer, Henry Charles Bodenheimer · 2009 · Springer eBooks
  4. Genetic Risk Markers for Hepatocellular Carcinoma in Patients with Alcoholic Liver Disease
    Pierre Nahon, Angéla Sutton, Marianne Ziol, Jessica Zucman‐Rossi, Jean–Claude Trinchet, Nathalie Ganne‐Carrié · 2015 · Hepatic Oncology
  5. ALTERACIONES EN LA HOMEOSTASIS DEL COLESTEROL HEPÁTICO Y SUS IMPLICACIONES EN LA ESTEATOHEPATITIS NO ALCOHÓLICA
    Joel Vega‐Badillo · 2016 · TIP Revista Especializada en Ciencias Químico-Biológicas
  6. The rs4686434 variant in the fetuin B (FETUB) locus is associated with intrahepatic triglyceride content in obese Chinese adults
    Zhibin Li, Mingzhu Lin, Changqin Liu, Zheng Chen, Dongmei Wang, Xiulin Shi, Shuyu Yang, Xuejun Li · 2018 · Journal of Diabetes
  7. Reply to: “Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients”
    Eric Trépo, Pierre Pradat, Jeanette J. McCarthy, Hans Ludger Tillmann · 2012 · Journal of Hepatology
  8. Describing the role of ethnicity in the progression of NAFLD: Easier said than done?
    Edward W. Holt · 2012 · Hepatology
  9. Understanding the Role of PNPLA3 Genetic Variants in Patients with Chronic Hepatitis C Infection
    Alessio Aghemo · 2012 · Digestive Diseases and Sciences
  10. Which Method is Superior in the Diagnosis of Nonalcoholic Fatty Liver and Steatohepatatis in Children?
    Farkhondeh Razmpour, Mohsen Nematy, Mahmoud Belghaisi Naseri, Zahra Dehnavi, Azita Ganji, Hasan Vatanparast, Ali Taghipour, Mohsen Azimi–Nezhad, Seyed Ali Alamdaran · 2017 · Hepatitis Monthly
  11. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan Takuya KitamotoAya KitamotoMasato YonedaHideyuki HyogoHidenori Ochi • Takahiro NakamuraHajime TeranishiSeiho MizusawaTakato UenoKazuaki Chayama • Atsushi NakajimaKazuwa NakaoAkihiro SekineKikuko Hotta
    Kikuko Hotta, Masato Yoneda, Atsushi Nakajima, Hyogo H. Ochi, Kazuaki Chayama, Takehiro Nakamura, Hitoshi Teranishi, Seiho Mizusawa, Takato Ueno, Kazuwa Nakao · 2013
  12. Pediatric Nonalcoholic Fatty Liver Disease
    Michael I. Goran · 2016 · CRC Press eBooks
  13. Role of molecular genetic factors in pathogenesis and diagnosis of non-alcoholic fatty liver disease (literature review and own data)
    D. V. Sidorenko, В. Д. Назаров, Sergey Vladimirovich Lapin, Vladimir Leonidovich Emanuel · 2020 · Medical alphabet
  14. Impact of Host Genetic Variants on Natural History and Treatment of Hepatitis C Virus Infection
    Karolina Rembeck · 2015 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  15. The reversibility of type 2 diabetes
    Sarah Steven · 2016
  16. Non‐alcoholic Fatty Liver Disease
    Yaron Rotman, Devika Kapuria · 2020
  17. Clinical Genomics of NAFLD
    Frank Lammert · 2020 · Wiley eBooks
  18. Hepatic Lipid Droplets in Liver Function and Disease
    Douglas G. Mashek, Wenqi Cui, Linshan Shang, Charles P. Najt · 2020 · Wiley eBooks
  19. Therapeutic Approaches for Nonalcoholic Steatohepatitis ( NASH )
    Ralf Glatthar, Robert H. Arch · 2021 · Wiley eBooks
  20. Frequency of I148M Polymorphism of the PNPLA3 Gene Associated with a Risk of Steatosis and Liver Fibrosis in Residents of the Republic of Sakha (Yakutia)
    Снежана Спиридоновна Слепцова, Aleksander E. Efimov, Nikolay Michaylovich Gogolev, П. Г. Петрова, Sergey Semenov, Голикова Полина Иннокентьевна, A. L. Danilova, Filip Filippovich Vasilev, A. E. Yakovleva, A. L. Sukhomyasova et al. · 2021 · Preprints.org
  21. Letter to the Editor: Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort
    Rabia Irfan, Satesh Kumar · 2023 · Hepatology
  22. A genome-wide ATLAS of liver chromatin accessibility reveals that sex dictates diet-induced nucleosome dynamics
    Zhengyi Zhang, Vivien Su, Carrie B. Wiese, Lijing Cheng, Dan Wang, Ya Cui, Aneesh S. Kallapur, Jason Kim, Xiaohui Wu, Peter H. Tran et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Genetic Predisposition to NAFLD and NASH: Implications for Pathogenesis, Diagnosis, Prevention, and Management
    Quentin Mark Anstee, Ann K. Daly, Christopher Paul Day · 2013 · Wiley eBooks
  24. Non-invasive elastography-based study in patients with chronic liver diseases identifies variant adiponutrin as common fibrosis risk factor
    Marcin Jan Krawczyk · 2011 · Publications of the UdS (Saarland University)
  25. Chronic HCV and Steatosis
    Dawn McDowell Torres, Stephen A. Harrison · 2011 · Springer eBooks
  26. Susceptibility to chronic liver disease
    Maria Antonella Burza · 2015 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  27. A Functional Polymorphism in the Epidermal Growth Factor Gene Independently Predicts Clinical Decompensation in HCV-Related Cirrhosis
    Kara B. Johnson · 2014 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  28. Nonalcoholic Fatty Liver Disease: is It All in the Genes?
    Dawn McDowell Torres, Stephen A. Harrison · 2010 · Hepatology
  29. MOLECULAR GENETICS OF PATATIN-LIKE PHOSPHOLIPASE DOMAIN-CONTAINING 3 AND CHRONIC LIVER DISEASE
    Carlo Pirazzi · 2014 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  30. Genetic Pleiotropies of Obesity
    Bratati Kahali, Elizabeth K. Speliotes · 2013 · Springer eBooks
  31. PNPLA3 Polymorphisms and Liver Aminotransferase Levels in a Mexican
    Hui‐Qi Qu, Anne R. Rento, Megan L. Groe, Shaper Mirza, Lu Yang, Craig L. Hanis, Michael B. Fallon, Eric Boerwinkle, Susan P. Fisher‐Hoch, Joseph B. McCormick · 2012
  32. Central JSM Gastroenterology and Hepatology
    Monjur Ahmed∥ · 2014
  33. Is NAFLD different in absence of metabolic syndrome?
    Yusuf Nadir Yilmaz · 2016
  34. Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations
    Arthur Zimmermann · 2016 · Springer eBooks
  35. PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
    Olena Vadymivna Kolesnikova, Valeriya Danilovna Nemtsova, Rajkumar Rajendram · 2016 · Exposure and Health
  36. The Genetic Mechanisms Underlying Human Obesity
    Stephen J. Clark · 2012
  37. The Role of Bacterial Products and Intestinal Microbiota in Non-Alcoholic Fatty Liver Disease
    Da Silva, Hannah Luke Elizabeth · 2015 · TSpace (University of Toronto)
  38. An in vitro model to study the adipose tissue toll-like receptor -mediated effects of gut microbiota on non-alcoholic fatty liver disease development
    Sakari Välimäki · 2017 · Jyväskylä University Digital Archive (University of Jyväskylä)
  39. The rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia
    Liubov A. Sydykova, Yakutsk, the Republic of Sakha (Yakutia), Russia, Х.А. Куртанов, Natalia Borisova, Nadejda Pavlova, К.М. Степанов, Sardana V. Markova, Albert Makarov, Sardana Alekseeva, Uliana I. Antipina · 2018 · International Journal of Biomedicine
  40. Effects of the PNPLA3–SNP rs738409 on Serum Transaminase levels are modified by body mass index and alcohol consumption
    Peter J. Meffert · 2018 · Biometrics & Biostatistics International Journal
  41. Role of ceacam1 and shp1 in the regulation of insulin sensitivity and hepatic glucose and lipid metabolism
    Elaine Xu · 2012 · Corpus Université Laval (Université Laval)
  42. Reply to Drs Mantovani and Zusi
    Cristiane Alves Villela‐Nogueira, Nathalie Carvalho Leite, Carolina M. Machado, Claudia R.L. Cardoso, Gil Fernando Salles · 2019 · Nutrition Metabolism and Cardiovascular Diseases
  43. Metabolic effects of dipeptyl peptidase 4 inhibitor in type 2 diabetes
    Mavin Macauley · 2016
  44. Adipokines in patients with hypertensive disease with obesity in the dynamics of combined antihypertensive therapy
    Павло Григорович Кравчун, O. I. Kadykova, U. S. Herasymchuk · 2021 · Regulatory Mechanisms in Biosystems
  45. Diabetes and Liver Disease
    Robert P. Hirten, Henry Charles Bodenheimer, David Bernstein · 2017 · Springer eBooks
  46. Diabetes and Liver Disease
    Robert P. Hirten, Henry Charles Bodenheimer, Douglas Meyer, David Bernstein · 2017 · Springer eBooks
  47. Diabetes and Liver Disease
    Robert P. Hirten, Henry Charles Bodenheimer, David Bernstein · 2015 · Springer eBooks
  48. PNPLA3/adiponutrin I148M gene variant in nonalcoholic fatty liver disease in Egyptian children and adolescents
    Dina S. Ata, Mohy A.E. Awad, Manal Abd El-Wahed Eid, Khaled I. ElShafey, Ola Taha · 2021 · Alexandria Journal of Pediatrics
  49. Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations
    Arthur Zimmermann · 2016 · Springer eBooks
  50. PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease
    Olena Vadymivna Kolesnikova, Valeriya Danilovna Nemtsova, Rajkumar Rajendram · 2017 · Biomarkers in disease
  51. Reply:
    Kiran M. Bambha, Nathan M. Bass · 2012 · Hepatology
  52. Pathophysiologie: Genetik
    Susanne Nicole Weber, Frank Lammert · 2022 · Springer eBooks
  53. In Silico and In Vitro Analyses of PNPLA3 rs738409 C>G Polymorphism in Patients With Non-alcoholic Fatty Liver Disease
    Fatemeh Safari, Zeinab Imani-Saber, Sima Mozafari, Saeed Lotfi, Nahid Einollahi · 2022 · Disease and Diagnosis
  54. Global epidemiology of NAFLD
    Margaret Li Peng Teng, Cheng Han Ng, Mark Dhinesh Muthiah, Mindie H. Nguyen, Daniel Q. Huang · 2024 · Elsevier eBooks
  55. Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitis
    Elena Sena, Frank Tacke, Quentin Mark Anstee, Nicholas A. Di Prospero, Mette Skalshøi- Kjær, Sergio Muñoz, Jesús Rivera‐Esteban, Alba Jiménez-Masip, Jesús M. Bañales, María Martínez-Gómez et al. · 2024 · Communications Medicine
  56. Prevalence and effect of PNPLA3 and TM6SF2 gene polymorphism on the course of non-alcoholic fatty liver disease
    N. S. Branovitskaya, А. Л. Калинин, А. А. Ковалев, M. N. Yatsuk, E. A. Lipskaya · 2025 · Health and Ecology Issues
  57. Papel de las lipasas metabólicas y la lipotoxicidad en el desarrollo de esteatosis hepática y esteatohepatitis no alcohólica
    Alba Berlanga, Esther Guiu‐Jurado, José Antonio Porras, Gemma Aragonès, Teresa Auguet · 2015 · Clínica e Investigación en Arteriosclerosis
  58. Additional file 1 of Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study
    Matthias Claus, Antoni, Christoph, Hofmann, Bernd · 2021 · Figshare
  59. Integrated chromatin and transcriptomic profiling reveals sex-specific mechanisms of gene regulation in hepatic nutrient responses
    Zhengyi Zhang, Vivien Su, Carrie B. Wiese, Lijing Cheng, Dan Wang, Ya Cui, Aneesh S. Kallapur, Jason Kim, Xiaohui Wu, Peter H. Tran et al. · 2026 · PLoS Biology
  60. Precision medicine in steatotic liver disease
    Vitchapong Prasitsumrit, Vincent Lingzhi Chen · 2026 · Current Opinion in Gastroenterology
  61. Muscle Mass as a Causal Factor in MASLD: Insights from a Genome-Wide Association Study and Bidirectional Mendelian Randomization Using Data from the Korean Genome and Epidemiology Study
    Kiook Baek, Jung Gil Park, Yu Rim Lee, Soo Young Park, Young Oh Kweon, Won Young Tak · 2026 · Gut and Liver
  62. Pnpla3/Adiponutrin Deficiency in Mice Does Not Contribute to Steatohepatitis, Fibrosis or Cholestatic Liver Injury
    Robert McMahon, Thierry Claudel, Claudia Fuchs, Tatjana Stojaković, Hubert Scharnagl, Robert Zimmermann, Guenter Haemmerle, Erin E. Kershaw, Michael Trauner · 2026 · International Journal of Negative Results